Selbyville, Delaware, June 19, 2023 (GLOBE NEWSWIRE) --
Flow Cytometry Market size will surpass USD 11 billion by 2032, driven by advancements in biotechnology and the pharmaceutical industries. For instance, Becton, Dickinson and Company announced a study in collaboration with the EMBL (European Molecular Biology Laboratory) to profile a new flow cytometry innovation designed to add image-based decisioning and fluorescence imaging for individual cell sorting at high speeds.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5897
Flow cytometry is a powerful technique used in various fields, including immunology, oncology, and drug discovery, to analyze and characterize cells based on their physical and chemical properties. The process is gaining immense significance as it enables researchers and healthcare professionals to gain valuable insights into cellular functions, disease mechanisms, and therapeutic responses.
Bead-based flow cytometry to become preferred technology for modern immunoassay workflows
Bead-based flow cytometry market size is set to grow at a rapid pace, offering higher throughput and multiplexing capabilities. This approach enables the simultaneous analysis of multiple analytes, thereby increasing the efficiency of the process. These assays have revolutionized immunoassay workflows and are widely used in areas such as protein analysis, cell signaling, and molecular biology. As a result, bead-based technology has become a popular choice for researchers and clinicians.
Cell sorting to remain a key application area
Flow cytometry market size from the cell sorting segment is expected to witness rapid development through 2032, driven by the increasing demand for personalized medicine and cell-based therapies. Cell sorting plays a crucial role in isolating specific cell populations based on their characteristics, facilitating further analysis or downstream applications. The ability to sort cells based on various parameters, such as size, morphology, and molecular markers, has enabled advancements in fields such as stem cell research, cancer biology, and regenerative medicine. The demand for high-speed, high-purity cell sorting technologies has surged, leading to the development of advanced flow cytometry instruments capable of sorting millions of cells per second.
Europe to emerge as major growth hub for flow cytometry industry
Europe will hold a commendable share of the global flow cytometry market by 2032, with countries such as Germany, France, and the United Kingdom leading the way in terms of research and development. In November 2022, a University of Birmingham spinout, ChromaTwist Ltd, received equity investment worth USD 573,000 for the development of its new class of fluorescent dyes designed for flow cytometry reagents.
Additionally, collaborations between academic institutions, research organizations, and industry players are fostering innovation and driving the development of cutting-edge flow cytometry technologies. With its emphasis on scientific excellence and healthcare advancements.
Request for Report Customization @ https://www.gminsights.com/roc/5897
Flow Cytometry Market Players
Some of the key companies operating in the flow cytometry industry include Becton, Dickinson and Company, Sony Biotechnology, Inc., Thermo Fisher Scientific, Inc., Danaher Corp, Miltenyi Biotec, Inc., Agilent Technologies, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., and Luminex Corporation among others
Flow Cytometry Industry News
- Feb 2023 - Bio-Rad Laboratories announced a strategic partnership with Cytek Biosciences, under which Cytek would develop and market new reagent products using use Bio-Rad's StarBright Dyes to support applications on its Northern Lights and Aurora flow cytometry systems.
Partial Table of Contents (ToC) of the report:
Chapter 3 Flow Cytometry Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing disease burden of cancer and infectious diseases such as HIV/AIDS
3.2.1.2 Technological advancements in flow cytometry instruments and reagents
3.2.1.3 Rise in use of flow cytometry techniques in research activities
3.2.1.4 Increasing demand for point-of-care diagnostics
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of flow cytometry instruments
3.2.2.2 Stringent regulatory guidelines
3.3 Growth potential analysis
3.3.1 By products and services
3.3.2 By technology
3.3.3 By application
3.3.4 By usage
3.3.5 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Future market trends
3.7 Flow cytometry – Process overview
3.8 Technology landscape
3.9 Sales channel analysis
3.10 Pricing analysis
3.11 Application scenario
3.12 Patent analysis
3.13 Porter’s analysis
3.14 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix
4.4 Vendor matrix analysis
4.5 Strategy dashboard, 2022
Browse Our Reports Store - GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
